>RESEARCH ON HANTAVIRUS AND OTHER EMERGING VIRAL THREATS
>>NIH GUIDE, Volume 24, Number 13, April 7, 1995
>>RFA AVAILABLE: AI-95-013
>>P.T. 34; K.W. 1002045, 0715125
>>National Institute of Allergy and Infectious Diseases
>>Letter of Intent Receipt Date: June 1, 1995
>Application Receipt Date: July 20, 1995
>>The National Institute of Allergy and Infectious Diseases (NIAID)
>recently co-funded two studies by the Institute of Medicine dealing
>with emerging diseases. They concluded that the threat posed by
>disease-causing microbes may be expected to continue and intensify in
>coming years. Factors influencing the pattern of emergence and
>distribution of infectious diseases in general include those
>associated with the microbial agent itself, the agent's hosts and
>vectors, and the environment in which agent and host interact.
>However, for many infectious agents, these factors are poorly
>understood. Nonetheless, knowledge of these principles is essential
>in planning strategies to prevent, treat, and control these diseases.
>>Applications are invited for program project (P01) grants to
>establish Emerging Viruses Research Groups (EVRG) performing
>multi-disciplinary, collaborative research on emerging viral diseases
>in general, with special emphasis on hantaviruses. The EVRG should
>develop coordinated basic and applied research projects yielding new
>data that will enhance prediction, prevention, treatment, and control
>of emerging and re-emerging viral diseases threatening the U.S.
>Multi-project grants support broadly-based research programs that
>have a central research focus and a minimum of three inter-related
>research projects around this central theme. An EVRG must have at
>least one of the component research projects dealing with
>hantaviruses, with at least one of the other component projects
>focused on another emerging viral disease. An EVRG is encouraged to
>include coordinated multi-discipline projects. Since other
>initiatives are available to support research on influenza,
>hepatitis, herpes, papilloma, respiratory syncytial, measles, and
>retroviruses/HIV, projects on these viruses will not be considered
>responsive to this RFA. Approximately two awards are anticipated for
>a first year total cost of $1.0 million.
>>HEALTHY PEOPLE 2000
>>The Public Health Service (PHS) is committed to achieving the health
>promotion and disease prevention objectives of "Healthy People 2000,"
>a PHS-led national activity for setting priority areas. This Request
>for Applications (RFA), Research on Hantavirus and Other Emerging
>Viral Threats, is related to the priority area of immunization and
>infectious diseases. Potential applicants may obtain a copy of
>"Healthy People 2000" (Full Report: Stock No. 017-001-00474-0 or
>Summary Report: Stock No. 017-001-00473-1) through the
>Superintendent of Documents, Government Printing Office, Washington,
>DC 20402-9325 (telephone 202-783-3238).
>>This RFA, which describes the research objectives, application
>procedures, review considerations, and award criteria for this
>program, may be obtained electronically through the NIH Grant Line
>(data line 301-402-2221) and the NIH GOPHER (gopher.nih.gov), and by
>mail and email from the program contacts listed below.
>>James M. Meegan, Ph.D.
>Division of Microbiology & Infectious Diseases
>National Institute of Allergy & Infectious Diseases
>Solar Building, Room 3A-15
>6003 Executive Boulevard MSC 7630
>Bethesda, MD 20892-7630
>Telephone: (301) 496-7453
>FAX: (301) 402-0659
>Email: jm75v at nih.gov>>END ************************************************************
Jack Woodall, ProMED List Moderator, NY State Dept. of Health, Albany NY
e-mail: woodall at wadsworth.org